Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03128177 · ClinicalTrials.gov registry record · NA

Nocturnal Hypertension and Non-Dipping Blood Pressure

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT03128177 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 59 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03128177, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

The purpose of this study is to determine if high salt diet contributes to high nighttime blood pressure. The investigators will determine if high compared to low salt diet increases 24-hour blood pressure levels. The investigators will also determine if high salt diet affects blood vessel stiffness, cardiac output, and sleep apnea. The study will also determine how high salt diet affects the activity of certain genes related to control of blood pressure. A total of 60 participants will be enrolled in the study.

Interventions

  • DIETARY_SUPPLEMENT Dietary sodium

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2016-01-01
Est. Completion 2020-03-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03128177

The ClinicalTrials.gov registry entry for NCT03128177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dietary sodium is the first listed.

NCT03128177 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03128177 about?

NCT03128177 is a clinical study titled "Nocturnal Hypertension and Non-Dipping Blood Pressure". The purpose of this study is to determine if high salt diet contributes to high nighttime blood pressure. The investigators will determine if high compared to low salt diet increases 24-hour blood pressure levels. The investigators will also determine if high salt diet affects blood vessel stiffness...

What is the current status of trial NCT03128177?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2016-01-01. Estimated completion is 2020-03-31.

What interventions are being tested in trial NCT03128177?

The interventions under investigation include: Dietary sodium (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03128177?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.